Side population (SP) cells were isolated by FACS from a human amnion mesenchymal cell (AMC) layer soon after enzyme treatment. The yield of SP cells from AMC layer (AMC-SP cells) was about 0.1-0.2%. AMC-SP cells grew well with cell doublings of 40-80 days of culture. FACS profiles and immunocytostaining showed that AMC-SP cells were composed of two different cells immunologically: HLA I − /II − and HLA I + /II − . Oct-3/4 was detected in the nucleus of AMC-SP cells, when the culture was examined at the third, sixth, and 10th passages. RT-PCR showed that AMC-SP cells expressed the Oct-4, Sox-2, and Rex-1 genes. Immunocytochemistry revealed that all AMC-SP cells were vimentin + , CK19 + , and nestin + . In addition, flow cytometry analysis showed that SP cells had high expression of CD13, CD29, CD44, CD46, CD49b, CD49c, CD49e, CD59, CD140a, and CD166 but low expression of CD 49d, and CD51. No evidence of expression was obtained for CD34, CD45, CD49a, CD56, CD90, CD105, CD106, CD117, CD133, CD271, or Flk-1. Upon appropriate differentiation protocols, AMC-SP cells differentiated to several cell lineages such as neuroectodermal, osteogenic, chondrogenic, and adipogenic cells. These results indicate that AMC-SP cells have multilineage potential to several cell lineages with unique immunological characteristics such as HLA I − /II − or HLA I + /II − . AMC-SP cells should be of considerable value for regenerative medicine because they do not induce acute rejection after allotransplantation, they do not cause ethical issues, and there is no limit of supply.
INTRODUCTION
have the potential to proliferate and differentiate into diverse types of cells, such as fibroblasts, chondroblasts, and osteoblasts (10) . Sakuragawa et al. reported that hu-The human amnion membrane consists of two cell layers-the amnion epithelial layer and the mesenchy-man AMCs can express the phenotype of neuroglial progenitor cells; this was the first report providing the evi-mal layer-with a basement membrane between. The amniotic epithelial layer directly faces the amniotic fluid.
dence that AMCs can differentiate in vitro to form novel tissue types (17) . In't Anker et al. showed mesenchymal The mesenchymal layer is a loose tissue located under the basement membrane and attached to the chorionic stem cells in amniotic membrane with bipotential osteogenic and adipogenic differentiation (7) . Also Ports-villi. Importantly, those two cell layers are derived from fetal organs. The amnion epithelial and mesenchymal man-Lanz et al. reported placental mesenchymal stem cells isolated from the first and third trimester that were layers originate from different embryological sites; the former is derived from the epiblast and the latter from able to differentiate to several cell lineages (15) . Recently, Alviano et al. demonstrated multipotent mesen-the primitive streak. Human amnion mesenchymal cells (AMCs) migrate widely and participate in the formation chymal stem cells with the ability to differentiate into endothelial cells in vitro (1) . of extra-embryonic mesodermal tissue that supports the epithelium of the amnion and yolk sac as well as the Multipotential stem cells are undifferentiated cells, but, upon induction, differentiate to the cells that consti-chorionic villi (3) . It has been suggested that AMCs tute various tissues. These stem cells are therefore of otic mesenchymal layer, was treated with an enzyme mixture (0.1% papain, 1 mg/ml collagenase, 0.01% importance in the fields of organ reconstruction and tissue engineering. Two multipotential stem cells have been DNase, and 0.1% Dispase) at 37°C for 1 h with shaking. After the enzyme treatment, the dispersed cells were fil-described: myeloid stem cells obtained from bone marrow, and cord blood stem cells. Most of the reported cell tered through a 100-µm cell strainer (BD Falcon) and centrifuged at 1000 rpm for 5 min as AMCs. The AMCs lines for regenerative technology have been developed for autotransplantation. To achieve allotransplantation were suspended in DMEM/F12 (1:1) supplemented with 10% fetal bovine serum (FBS), 10 ng/ml human leuke-successfully, we must overcome the problems of histoincompatibility of the candidate donor stem cells. As mia-inhibition factor (hLIF, Chemicon, USA), and 0.2 mM 2-mercaptoethanol (2-ME, Sigma, USA), and cul-shown in a previous study, amnion-derived cells are immunologically naive and acute rejection is not evident tured with a collagen-coated dish in a humidified 5% CO 2 incubator at 37°C. after allotransplantation (18). Thus, human amnion-derived stem cells are an attractive prospect for studies on the Isolation and Culture of Side Population Cells feasibility of purification and cultivation of stem cells in AMCs for transplantation.
Recently, a method for purifying stem cells using the The primary cultured AMCs, treated with trypsin, were suspended at 10 6 /ml in DMEM (Sigma) supple-fluorescent dye Hoechst 33342 was reported (4) . Hoechst 33342 has high cell membrane permeability and binds mented with 2% FBS and 10 mM HEPES buffer (Sigma) and placed in a water bath at 37°C for 15 min. to the "AT" nucleotide sequence of DNA; cycling cells can be stained without affecting their viability. This dye
The cells were incubated with the Hoechst 33342 (Sigma) to stain the nuclei. To the controls, 50 µM vera-can therefore be used to study the cell cycle of live cells. Upon ultraviolet light irradiation, Hoechst 33342 emits pamil (Sigma; 50 mM stock dissolved in 95% ethanol) was added to block the function of the pump that ex-at two wavelengths: 450 and 675 nm. Goodell et al. stained mouse bone marrow cells with Hoechst 33342 cludes the dye during incubation. The staining was terminated by placing the cells on ice followed by centrifu-and subjected them to fluorescent-activated cell sorting (FACS) (5). They carried out two-dimensional analysis gation at 4°C, 1,500 rpm for 5 min. Propidium iodide (PI) was added at a concentration of 2 µg/ml to exclude using fluorescence intensity at 675 nm along the abscissa and fluorescence intensity at 450 nm along the dead cells. Analysis and sorting of the SP cells were carried out using the EPICS ALTRA (Beckman Coulter, ordinate. As a result, they found a cell population with low Hoechst fluorescence and named it the "side popu-Fullerton, CA, USA). The sorted SP cells in AMCs (AMC-SP cells) were lation cells" (hereafter referred to as "SP cells"). They also found that SP cells contain hematopoietic stem cells cultured in DMEM/F12 (1:1) with 10% FBS, 10 ng/ml hLIF, and 0.2 mM 2-ME on a type I collagen-coated at a high frequency. In subsequent studies, they also found SP cells in human, simian, swine, canine, and ze-dish. When the culture reached 90% confluence, the cells were recovered with 0.1% trypsin-EDTA and replated at bra fish bone marrows and in the liver and muscle.
In the present report, we designed a protocol for iso-a density of 10 4 /cm 2 . lation and characterization of SP cells from the AMC.
Stem Cell Marker Analysis We termed the isolated cells AMC-SP cells. We found that approximately half of the AMC-SP cells were dou-For immuofluorescence analysis of the cellular Oct-3/4 expression, AMC-SP cells were fixed with 4% para-ble negative for classical HLA I (A, B, C) and HLA II (DR, DQ, DP), indicating that they are good candidates formaldehyde (PFA) for 15 min and permeabilized with cold methanol. Cells were incubated with diluted anti-for use in allotransplantation. We describe here that AMC-SP cells are potent stem cells useful in regenera-human Oct-3/4 polyclonal antibody (1:200, Santa Cruz) for 1 h at room temperature. Thereafter, the cells were tive medicine.
washed and incubated with diluted Alexa Fluor 488 goat MATERIALS AND METHODS anti-rabbit IgG (1:500, Molecular Probes) for 45 min at Culture of Amnion Mesenchymal Cells 4°C. After washing, the florescence was detected and analyzed by using a confocal laser scanning microscope The AMCs were prepared as described previously from placenta after scheduled caesarean operation (17) .
(CLSM). The marker analyses were performed at third, sixth, and 10th passage. Informed consent was obtained and the local institutional review board approved all experiments. Briefly, For the gene expression analysis, total RNAs were extracted from AMC-SP cells with the High Pure RNA first human amniotic membrane separated from the placenta was treated with trypsin to remove the amniotic Isolation Kit (Roche Diagnostics, Mannheim, Germany). M-MuLV Reverse Transcriptase (Invitrogen, CA, USA) epithelial cells. Next, the trypsin-undigested layer, amni- 
was used to synthesize cDNAs from the total RNAs. CD105, anti-VD140a, and anti-Flk-1 (Santa Cruz, USA). Thereafter, the cells were washed with HBSS+, and in-Reverse transcription (RT) was performed at 37°C for 60 min under the following conditions: 1 µg of total cubated with Alexa Flour 488 goat anti-rabbit IgG or Alexa Flour 488 goat anti-mouse IgG for 30 min at 4°C. RNA, 100 U of M-MLV Reverse Transcriptase (Invitrogen), and 0.5 pmol of random primer (Roche, USA)
After three washes with PBS(−), the stained cells were analyzed by using the EPICS ALTRA. in a 20 µl volume. PCR was carried out under the following conditions: 2 µl of cDNA, 200 µM dNTPs, 10
Neurogenic, Osteogenic, Chondrogenic, pM each of forward and reverse primers (Table 1) , and and Adipogenic Differentiation Culture 2.5 U Taq DNA polymerase (Roche, USA) in a 50 µl volume, using DNA in a Thermal Cycler 480 (Perkin-
The neurogenic differentiation of AMC-SP cells was induced by the method described by Woodbury et al. Elmer, CA, USA). Target DNAs were amplified for 40 cycles with the following conditions: denaturation at (20) . Briefly, as the preinduction, AMC-SP cells were cultured in DMEM with 20% FBS and 10 ng/ml basic 95°C for 1 min, annealing at the optimal temperature for each primer set for 1 min, extension at 72°C for 1 min, fibroblast growth factor (bFGF) for 10-12 h. After the incubation, SP cells were rinsed twice with PBS(−) and and termination at 72°C for 7 min. The PCR fragments were electrophoresed on a 3% agarose gel and stained then cultured in the neurogenic induction medium consisted of DMEM supplemented with 100 µM BHA, 10 with ethidium bromide; the fragments were verified by comparison with the predicted band sizes.
µM forskolin, 2% dimethyl sulfoxide, 5 U/ml heparin, 5 nM K252a, 25 mM KCl, 2 mM valproic acid, 1 × N2 Flow Cytometry Analysis supplement, 10 ng/ml bFGF, and 10 ng/ml platelet-derived growth factor-BB (PDGF-BB) for 24 h. The surface markers of AMC-SP cells in the culture of fourth to seventh passages were characterized by flow
The osteogenic differentiation was induced with an osteogenic medium for 4 weeks with replenishing the cytometry analysis. The cells were gently trypsinized and incubated for 30 min at 4°C with primary antibodies medium twice a week (19) . The osteogenic medium consisted of DMEM supplemented with 10% FBS, 0.1 µM specific for human antigen. A variety of primary antibodies was used: anti-CD13, anti-CD29, anti-CD34, anti-dexamethasone, 50 µM ascorbic acid, 10 mM β-glycerol phosphate, and 10 ng/ml bone morphogenetic protein CD44, anti-CD45, anti-CD 46, anti-CD49a, anti-CD49b, anti-CD49c, anti-CD49d, anti-CD49 e, anti-CD49f, ant-(BMP). The chondrogenic differentiation was induced by the CD51, anti-CD56, anti-CD59, anti-CD90, anti-CD106, anti-CD117, anti CD166, and anti-CD271 (Immunotech, pellet culture of AMC-SP cells with a chondrogenic medium (6) . Briefly, trypsinized AMC-SP cells were placed USA); anti-HLA I and anti-HLA II (Ancell, USA); anti- in a 15-ml polypropylene tube and centrifuged at 1,000 0.35 mM L-prolin, 1 mM sodium pyruvate, 5.33 µg/ml linoleic acid-BSA (Sigma), 0.1% ITS (Becton Dickin-rpm for 5 min. The cells were resuspended in the chondrogenic medium with DMEM (Sigma), containing 1% son), and 10 ng/ml tumor growth factor-β3. The cells were recentrifuged at 1,000 rpm for 5 min to form a FBS, 0.1 µM dexamethasone, 0.17 mM ascorbic acid, pelleted cell mass at the bottom of the tube. The pellet mouse IgG. Immunostained cells were analyzed by confocal images using a confocal laser scanning microscope was cultured in the chondrogenic medium for 3 weeks and the medium was replenished with the fresh medium (CLSM). every 3 days.
Cytochemical Staining The adipogenic differentiation of SP cells was in-In osteogenetic induction, for evaluation of matrix duced with the adipogenic induction medium (DMEM mineralization, SP cells cultured with the osteogenic with 10% FBS supplemented with 0.5 µM hydrocortimedium for 4 weeks were fixed with 4% PFA for 15 sone, 0.5 µM 3-isobutyl-1-methylxanthine, and 60 µM min and stained with 1% Alizarin Red S (Sigma) soluindomethacine) for 2 weeks as described previously (2) . tion for 10 min. In addition, the alkaline phosphatase Immunocytochemistry activity, which is an osteoblast-specific marker, was detected with a commercial kit (Sigma).
AMC-SP cells, subjected for the differentiation to
Three weeks after the chondrogenic induction, SP neurons, osteocytes, and chondrocytes, were fixed and pellets were fixed in Bouin's fixative overnight at room incubated for 1 h with diluted primary antibodies spetemperature. Fixed pellets were dehydrated with series cific for the respective cell types. Primary antibodies of alcohol, embedded in paraffin, and cut into 5-µmused as neurogenesis markers were rabbit anti-human thick sections. Next the sections were deparaffinized neurofilament 150 kDa polyclonal antibody (1:300;
with xylene. The sections were stained with 1% alcian Chemicon), mouse anti-human glial fibrillary acidic problue (Sigma) in 0.1 N HCl for 30 min. To examine the expression of osteogenesis-and chonmonoclonal antibody (R&D systems) and rabbit antidrogenesis-specific mRNA, we performed the reverse human bone sialoprotein polyclonal antibody (Immuno transcription-polymerase chain reaction (RT-PCR) as Diagnostic) were used. As a chondrogenic-specific marker, described above. Primers used for RT-PCR analysis of mouse anti-human collagen type II antibody (Chemicon) the osteocyte and chondrocyte differentiation are shown was used. Secondary antibodies were Alexa Fluor 488
in Table 2 . goat anti-rabbit IgG and Alexa Fluor 568 goat anti-
Statistical Analysis
The number of positively stained cells using different antibodies was counted and expressed as the percent of positive cells per total counted cells. The results are presented as mean ± SD and were assessed with Student' ttest. The level of significance was set at p < 0.05.
RESULTS

Isolation of Side Population Cells From Human Amniotic Mesenchymal Cells
FACS profiles of AMCs stained with Hoechst 33342 are shown in Figure 1 . The area shown by the quadrilateral is that containing the SP cell fraction. Approximately 0.1-0.2% of AMCs were SP cells (Fig. 1A) . The SP cell fraction was completely separated from major cell populations by adding verapamil, a functional inhibitor of multidrug resistance (MDR) molecules (Fig. 1B) . We compared the proportions of SP cells/AMC among in culture (Fig. 1C ) was identical to that at about 40 Neuroectodermal Differentiation days (Fig. 1D) .
For the evaluation of the neuroectodermal differentiation potency, AMC-SP cells at the fourth to ninth pas-Phenotype of AMC-SP Cells sage were treated by the induction method described by By the immunocytochemical analysis, the Oct-3/4
Woodury et al. (20) . After the induction, some of AMCprotein was detected in the nucleus of most AMC-SP SP cells were changed morphologically to bipolar or cells during the 10th passages (Fig. 2 ). In addition, the multipolar cells with branched processes. Neural cell RT-PCR analyses revealed that the cells expressed Octmarkers such as Musashi-1, Tuj-1, NF-M, and MAP2 4, nestin, Sox-2, and Rex-1 (Fig. 3) .
were examined by immunocytochemistry (Fig. 6) , and The FACS analysis indicated that 43% of AMC-SP the cell percentages positive for several markers are cells were HLA I + (Fig. 4A ) but that no cells were HLA shown in Table 3 . II + (Fig. 4B ). By definition, therefore, 57% of AMC-SP Osteogenic, Chondrogenic, cells were HLA I − /HLA II + (double negative cells). We and Adipogenic Differentiation confirmed this using immunocytostaining (Fig. 4C) .
With immunocytostaining, all AMC-SP cells were found
For the evaluation of the mesodermal differentiation potential, AMC-SP cells at the fourth to seventh pas-to be vimentin + , CK19 + , and nestin + (data not shown). The FACS analysis showed that AMC-SP cells (4) (5) (6) (7) sages were induced to osteocytes, chondrocytes, and adipocytes. passages) were highly positive for CD13, CD29, CD44, CD46, CD49b, CD49c, CD49e, CD59, CD140a, and Osteogenic-induced AMC-SP cells changed from an elongated fibroblastic appearance to rounder shape after CD166 (Fig. 5 ). In addition, CD49d and CD51 were weakly positive. However, the analyses showed that the 1 week. Three more weeks after the induction, the calcium deposition was detected by Alizarin Red S staining cells were negative for CD34, CD45, CD49a, CD56, CD90, CD105, CD106, CD117, CD133, CD271, and (Fig. 7a) , and the cells were stained positively for alkaline phosphatase activity (Fig. 7b ). The expression of Flk-1 (data not shown).
bone sialoprotein was also detected in the osteogenic-FACS with UV laser. The FACS analysis results in each cell were plotted at coordinates obtained using the fluo-induced AMC-SP cells by immunofluorescent staining (Fig. 7c) . The RT-PCR analysis revealed that the os-rescence intensity at a wavelength of 675 nm along the abscissa and fluorescence intensity at 450 nm along the teogenic-induced cells expressed specific genes in osteogenesis such as Cbfa-1, alkaline phosphatase, osteo-ordinate. In agreement with previous studies, we found that a subpopulation of cells with low fluorescence in-pontin, and bone sialoprotein (Fig. 8) .
During the chondrogenic induction periods of 3 tensities at both wavelengths fell into a horn-like region protruding from the scatter of the main cell population weeks, the pelleted cell masses of AMC-SP cells continued to keep the spherical shape. The paraffin sections of ( Fig. 1) . These are the AMC-SP cells outlined in Figure  1 . Thus, AMC-SP cells can be recovered easily with the spheres revealed the presence of abundant extracellular matrix substances, such as those stained with alcian blue FACS apparatus. AMC-SP cells can be subcultured in DMEM/F12 (1: (Fig. 7d ) and anti-type II collagen antibodies (Fig. 7e ). In addition, the expression of Sox9, the chondrogenesis-1) supplemented with 10% FBS, 10 ng/ml of hLIF, and 0.2 mM 2-ME, on a collagen type I-coated dish in a 5% associated gene, was detected by RT-PCR (Fig. 8) .
After culturing the AMC-SP cells with the adipo-CO 2 incubator. AMC-SP cells can be expanded ex vivo up to about 40 population doublings. It is known that genic induction medium for 2 weeks, lipid vacuoles in the cytoplasm were detected by the oil red O staining other cell types can continue to proliferate in culture for longer periods. For example, several lines of MPCs (me- (Fig. 7f) .
sodermal progenitor cells from human bone marrow) are DISCUSSION known to continue to grow to about 60 population doublings (14) . Similarly, fetal blood MSCs (human mesen-We obtained SP cells from the AMC layer by using a standardized SP cell-separating method. The AMCs chymal stem/progenitor cells) can be expanded for at least 20 passages with a mean cumulative population were stained with Hoechst 33342 and subjected to doubling of 50.3 ± 4.5 (2) . At present, we know that marrow-derived MSCs. Portmann-Lanz et al. (15) reported that placental and fetal membrane mesenchymal AMC-SP cells appear to retain the characteristics of undifferentiated cells like embryonic stem cells because stem cells had the following phenotype: CD13, CD29, CD44, CD49c, CD73, CD90, CD105, CD166, and HLA they continued to express Oct-3/4 to at least 10 passages. I positive; CD14, CD34, CD45, and HLA II negative. In contrast, we found here that the AMC-SP cells were Alviano et al. (1) reported that amnion membranehuman mesenchymal stromal cells (AM-hMSCs) showed CD90 − , CD105 − , and HLA I low/− . In comparison to those studies about amnion-or placental-derived cells, AMC-an immunophenotypical profile positive for CD29, CD44, CD73, CD105, and CD166, and negative for CD14, SP cells showed the same phenotype such as positive activities to CD13, CD29, CD44, CD49b, CD140a, and CD34, and CD45, consistent with that reported for bone CD166 but negative to CD105. Regarding the phenotypes of other stem cells, hMSCs CD44, Flt1, etc., and high levels of CD13 and CD49b. The AMC-SP cells also express Sox-2 and Rex-1. These genes are located downstream of Oct-4. It has been re-However, when plated on type IV collagen or laminin instead of FN, those cells began to express CD44 and ported that Sox-2 and Rex-1 are undifferentiated stateretaining molecules activated by cooperation with FGF-HLA I, and resembled the phenotypes described in MSCs (14) . These results suggest that the signals pro-4 and Rox-1 (cofactor), respectively (12) . Thus, in the AMC-SP cells, the genes described above appeared to duced by interaction of integrins (α4β1 or α5β1) and adhesion molecules (type IV collagen, laminin, and fi-serve for keeping the cultured cells under the undifferentiated state. bronectin) are required for maintaining the MPC phenotypes at the primitive stage (16) . AMC-SP cells expressed Previously, we reported that AMCs express the phenotype of neurological progenitor cells. Nestin and Mu-integrin family proteins such as CD49b (integrinα2), CD49c (integrinα3), CD49d (integrinα4), and CD49e sashi1 were expressed in undifferentiated AMCs shown by immunocytostaining and RT-PCR (17) . In this study, (integrinα5), whereas CD49a (integrinα1), CD106, and E-cadherin were not expressed. AMC-SP cells were pos-we detected the expression of nestin but not Musashi1 in AMC-SP cells by RT-PCR. We also found that AMC-itive for mesenchymal stem cell markers such as CD13, CD29, CD44, CD49b, CD51, CD140a, and CD166, but SP cells have the multilineage potential to differentiate to several organ-or tissue-specific cells such as neurons, negative for Flk-1 and CD56, mesodermal and ectodermal stem cell markers. Thus, AMC-SP cells isolated in osteoblasts, chondrocyts, and adipocytes, as found in the other type of mesenchymal stem cells (1, 2, 14, 16) . the present study differ to some extent from previously reported stem cells in terms of phenotype characteristics.
As part of our characterization of AMC-SP cells, we tested their transformation activity using an in vitro col-Immunocytochemical analysis showed that the AMC-SP cells at the third, sixth, and 10th passage express ony assay. We found that AMC-SP cells did not form any colonies, whereas HeLa cells, used as a positive Oct-4 (POU5), a differentiation-inhibiting gene that serves to retain cells in the undifferentiated state (11) .
control, produced many large colonies. In addition, Figure 7 . Differentiation of AMC-SP cells into osteocytes, chondrocytes, and adipocytes. Osteogenic differentiation was demonstrated by Alizarin Red S staining (a), the alkaline phosphatase activity (b), and immunocytochemistry of (c) bone sialoprotein (green fluorescence). Chondrogenic differentiation was shown by staining with (d) alcian blue and immunocytochemical staining for (e) type II collagen (green fluorescence). Adipogenic differentiation was evaluated by accumulation of lipid vacuoles that were stained with oil red O (f).
ruses to tumor sites (13). To our knowledge, this is the first report describing an isolation method and characterization of SP cells from AMCs. Judging from the lack of evidence of transformation in vivo and in vitro, we believe that in several respects AMC-SP cells are superior to ES cells, which have problems of transformation and acute rejection after transplantation to overcome. vehicles for delivery of either therapeutic genes or vi-
